CAS: 35779-04-5; 1-(Tert-Butyl)-4-Iodobenzene

该化合物是一种有机化合物,其特征是用苯环替换成三丁基甲酯和碘原子,该化合物一般视温度而定,无色可粉黄色液体或固态,以水溶性相对较低而闻名,但在乙醇和乙醇等有机溶剂中可溶性可溶性;碘原子的存在具有独特的再活性,使该物质在各种有机合成反应中有用,包括核分裂生物替代和混合反应;三丁基乙基苯基化合物助长阻塞作用,影响化合物的再活性和稳定性;此外,1之三-丁基-4-二苯可以作为合成药物和农用化学物的前体;安全考虑包括在通风良好的地区处理该物质,并使用适当的个人防护设备,因为若吸入吸入或吸入,可能会对健康造成危害.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

4-tert-Butylaniline iodobenzene isobutyryl chloride tert-butylbenzene bis(4-tert-butylphenyl)amine tButyl iodobenzenedichloride4-tButyl iodobenzenedichloride 4,4'-di-tert-butylbiphenyl 1-(tert-butyl)-4-iodosylbenzene

合成工艺路线路线简述

  • 合成目标产物 1-Tert-Butyl-4-Iodobenzene 主要起始原料 1-Bromo-4-Tert-Butylbenzene
  • (文献来源)合成步骤主要原料 1-Bromo-4-Tert-Butylbenzene
4-叔丁基苯胺置于氢气,Sodium Nitrite,氢碘酸体系中,用 水 用作溶剂,以40%的收率获得1-叔丁基-3-碘苯
参考文献:芳基和乙烯基自由基的反应性:氢原子的提取或与亲核试剂的反应
标题:芳基和乙烯基自由基的反应性:氢原子的提取或与亲核试剂的反应
摘要:芳基和乙烯基自由基(两种基本的瞬态中间体)的反应性已经针对两个基本过程进行了研究:H 原子提取和与亲核试剂的反应(y-,在 Srn1 反应中).感兴趣的自由基是通过使用 Bu3Snh/aibn 系统或通过来自亲核试剂的光刺激电子转移从卤代芳烃或卤乙烯前体产生的,并且研究了竞争途径之间的中间自由基的分配.使用间接方法(例如研究竞争实验中的反应产物;使用自由基钟探针)和直接方法(例如通过闪光光解实验检测自由基)使以下速率常数成为获得(25 oc 时 M-1.s-1 中的所有值).对于苯基型自由基,确定了从溶剂 Me2So (2.8.106) 和 Ch3Cn (6.7.106) 中提取 H 的速率常数 (Kh) 以及与亲核试剂 (Ky) 如 Me3Ccoch2-离子 (3.3.109) 结合的速率常数.对于乙烯基自由基 Ph2C=c(.)Ph (7.),来自 Me2So (1.1.105),Ch3Cn
Doi:10.1002/1099-0690(200208)2002:16<2844::Aid-Ejoc2844>3.0.Co;2-9

海关参考信息

专利信息


专利号:US-2015239796-A1
优先权日:2014-02-19
标题:One pot synthesis of 18f labeledtrifluoromethylated compounds with difluoro(iodo)methane
发明人:RüHL THOMAS; RISS PATRICK; RAFIQUE WAQAS
权利人:UNIV OSLO
摘要:The present invention relates to compositions and methods for the synthesis of 18 F labeled compounds. In particular, the present invention relates to a copper (I) mediated one pot method for 18 F-trifluoromethylation of aromatic- or heteroaromatic halides with difluoro(iodo)methane (e.g., for use at PET imaging agents).

专利号:US-8053161-B2
优先权日:2006-09-25
标 题 :Resist composition, resin for use in the resist composition, compound for use in the synthesis of the resin, and pattern-forming method using the resist composition
发明人:WADA KENJI; SAEGUSA HIROSHI
权利人:FUJIFILM CORP
摘要:A resist composition comprises: (A) a resin capable of increasing its solubility in an alkali developer by action of an acid; (B) a compound capable of generating an acid upon irradiation with actinic ray or radiation; (C) a resin having at least one of a fluorine atom and a silicon atom; and (D) a solvent, wherein the resin (C) has a degree of molecular weight dispersion of 1.3 or less and a weight average molecular weight of 1.0×10 4 or less.

专利号:US-2009131660-A1
优先权日:2006-04-03
标 题 :SYNTHESIS OF 3-[4-(1,1-DIMETHYL-PROPYL)-PHENYL]-2-METHYL-PROPIONALDEHYDE AND cis-4--2,6-DIMETHYL-MORPHOLINE (AMOROLFINE)
发明人:BOITEAU JEAN-GUY; MUSICKI BRANISLAV
权利人:GALDERMA SA
摘要:3-[4-(1,1-Dimethyl-propyl)-phenyl]-2-methyl-propionaldehyde and cis-4-{3-[4-(1,1-dimethyl-propyl)-phenyl]-2-methyl-propyl}-2,6-dimethyl-morpholine (Amorolfine) are synthesized, first by Heck reacting a compound of general formula (VI): n n n n n n n n n n with 2-methyl-prop-2-en-1-ol of formula (VII): n n n n n n n n n n in the presence of a palladium catalyst and a base, in a solvent selected from among N,N-dimethylformamide, polar protic and non-polar organic solvents, and at a temperature ranging from 60° C. to 150° C., and then conducting an amino reduction by reacting the 3-[4-(1,1-dimethyl-propyl)-phenyl]-2-methyl-propionaldehyde of formula (II) with cis-2,6-dimethyl morpholine of formula (IV): n n n n n n n n n n in the presence of a reducing agent and in a solvent.

专利号:US-7151112-B1
优先权日:2001-09-04
标题:Pharmaceutical uses and synthesis of nicotinamides
发明人:CUTSHALL NEIL S; JEFFREY SCOTT C
权利人:UCB SA
摘要:This invention is directed to methods of using a compound of the formula n nand pharmaceutically acceptable salts thereof, wherein n, X, R 1 and R 2 are disclosed herein, for treating inflammatory events in an animal subject.

专利号:WO-0009116-A1
优先权日:1998-08-14
标 题:Grp receptor ligands
发明人:XIANG JIA-NING; KARPINSKI JOSEPH M; CHRISTENSEN SIEGFRIED B IV
权利人:SMITHKLINE BEECHAM CORP; XIANG JIA NING; KARPINSKI JOSEPH M; CHRISTENSEN SIEGFRIED B IV
摘要:Novel GRP receptor antagonists are provided. Methods of using the present compounds to antagonize GRP receptors are also provided. The present invention further involves the synthesis of the present compounds.

专利号:US-8679724-B2
优先权日:2005-12-09
标题 :Positive resist composition, resin used for the positive resist composition, compound used for synthesis of the resin and pattern forming method using the positive resist composition
石家庄市康博精细化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.kangbofine.com
电话: 0311-89689838 13780319075👤
📞石家庄市康博精细化工有限公司 ⚠️参考联系方式

销售电话:0311-89689838 13780319075
邮箱:sjzkbjxhg@163.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Koo, S., Science of Synthesis, (2010) 45, 1356.
摘要:Sumida, Y.; Ohmiya, H., Science of Synthesis Knowledge Updates, (2022) 3, 43.
摘要:Oishi, M.; Takikawa, H., Science of Synthesis Knowledge Updates, (2010) 4, 104.
摘要:Mérour, J.-Y.; Joseph, B., Science of Synthesis Knowledge Updates, (2016) 3, 352.
摘要:Lee, C.-F., Science of Synthesis Knowledge Updates, (2019) 3, 95.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知